Ignite Creation Date:
2024-05-05 @ 12:11 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00261378
Status:
COMPLETED
Last Update Posted:
2021-07-21
First Post:
2005-12-01
Brief Title:
Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation
Sponsor:
Boston Scientific Corporation
Organization:
Boston Scientific Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Liver Cancer |
Keywords:
| Name | View |
|---|---|
| Hepatocellular Carcinoma HCC | View |